Health Care Compliance & Regulatory

Overview

Participants in the complex, heavily regulated health care industry must comply with an ever-changing framework of regulations. Leveraging legal, consulting, government advocacy and policy experience, we bring in-depth knowledge and real-world action plans to address the federal and state requirements that impact your organization’s growth, operations and ability to serve your patients and your communities. We help assess and mitigate regulatory and compliance risks, reduce exposure and resolve compliance issues. We guide you through fraud investigations, whistleblower lawsuits, Stark and Anti-Kickback Statute voluntary disclosures, Medicare and Medicaid reimbursement audits, investigations and voluntary refunds. We also assist with investigations and reporting of HIPAA and other privacy law breach issues, including ransomware and malware attacks. And, as the health care industry continues to enhance its digital presence, we advise on evolving regulatory issues regarding e health, telemedicine and other forms of remote health care service delivery.

Insights & Events

Latest

最新 January 2026

Key Updates in FDA’s 2026 General Wellness and Clinical Decision Support Software Guidance

Greater Clarity, Transparency, and Alignment in Digital Health Regulation
9 min read
最新 January 2026

Three District Courts Quash DOJ Subpoenas Investigating Gender-Affirming Care

Federal Courts Demand Proper Purpose for DOJ Inquiries Into Gender-Affirming Treatments
9 min read
最新 December 2025

Significant Drug & Device Developments of 2025

Drug & Device Companies Need to Be Vigilant and Nimble in Adapting to These Shifts
17 min read
最新 November 2025

Potential Challenges to State AI Laws; Senate Hearing on AI; and More Developments

Artificial Intelligence Briefing
6 min read
最新 November 2025

What Does the Agreement to Reopen the Federal Government Mean for Health Policy Interests?

And What Opportunities May Lie Ahead?
5 min read
最新 November 2025

SCOTUS Weighs Trump Administration’s Tariff Authority Under IEEPA; Pharma and Device AI; and More

Biopharma & Medical Devices Briefing
7 min read
Speaking Engagement Recap November 07, 2025

Data, Dangers, & Developments in Drug Supply Chain Security & Safety

American Society for Pharmacy Law: 2025 Developments in Pharmacy Law
1 min read
Speaking Engagement Recap September 10, 2025

Understanding New PBM Laws and Drug Cost Developments Through Real-World Scenarios: Legal & Strategic Insights - Minneapolis, MN

2025 Health Law Institute
1 min read
News August 2025

Jonathan Keller and Helen Tuttle Recognized in 2025 New Jersey Legal Awards

1 min read
Press Release May 2025

Faegre Drinker Welcomes Former Senate HELP Committee General Counsel Barrett Tenbarge to Government and Regulatory Group

3 min read
Insights
最新 January 2026

Key Updates in FDA’s 2026 General Wellness and Clinical Decision Support Software Guidance

Greater Clarity, Transparency, and Alignment in Digital Health Regulation
9 min read
最新 January 2026

Three District Courts Quash DOJ Subpoenas Investigating Gender-Affirming Care

Federal Courts Demand Proper Purpose for DOJ Inquiries Into Gender-Affirming Treatments
9 min read
最新 December 2025

Significant Drug & Device Developments of 2025

Drug & Device Companies Need to Be Vigilant and Nimble in Adapting to These Shifts
17 min read
最新 November 2025

Potential Challenges to State AI Laws; Senate Hearing on AI; and More Developments

Artificial Intelligence Briefing
6 min read
最新 November 2025

What Does the Agreement to Reopen the Federal Government Mean for Health Policy Interests?

And What Opportunities May Lie Ahead?
5 min read
最新 November 2025

SCOTUS Weighs Trump Administration’s Tariff Authority Under IEEPA; Pharma and Device AI; and More

Biopharma & Medical Devices Briefing
7 min read
最新 October 2025

California’s Frontier Artificial Intelligence Act & More Developments

Artificial Intelligence Briefing
7 min read
媒体报道 October 2025

Libby Baney Comments on Uncertainty in Prescription Drug Market With the Washington Post

1 min read
发表文章 October 2025

Defining Child Health Research to Guide Equitable Federal Appropriations

Journal of Pediatrics
1 min read
发表文章 October 2025

'Most-Favored Nation' Drug Pricing: Impacts on the Pharmacy Supply Chain

National Association of Boards of Pharmacy’s Innovations
1 min read

Meet The Team

Meet The Team